Mississippi HB 718: Opioid use disorder; require substance use disorder facilities to provide pregnant women with onsite access to certain treatments.

Bill Text

H. B. No. 718 *HR31/R285* ~ OFFICIAL ~ G1/2
25/HR31/R285
PAGE 1 (RF\JAB)

To: Public Health and Human
Services
MISSISSIPPI LEGISLATURE REGULAR SESSION 2025

By: Representative Summers

HOUSE BILL NO. 718

AN ACT TO REQUIRE EACH SUBSTANCE USE DISORDER FACILITY THAT 1
PROVIDES TREATMENT FOR OPIOID USE DISORDER TO PREGNANT WOMEN TO 2
PROVIDE ONSITE ACCESS TO AT LEAST ONE FORM OF FDA-APPROVED OPIOID 3
AGONIST TREATMENT; TO DEFINE THE TERM "SUBSTANCE USE DISORDER 4
FACILITY" AS A FACILITY OR PROGRAM OPERATED OR CERTIFIED BY THE 5
STATE DEPARTMENT OF MENTAL HEALTH THAT PROVIDES TREATMENT TO 6
PERSONS WITH SUBSTANCE USE DISORDERS; TO DEFINE THE TERM "ONSITE 7
ACCESS" AS DELIVERY OF THE TREATMENT TO THE PATIENT AT THE 8
LOCATION OF THE SUBSTANCE USE DISORDER FACILITY; TO REQUIRE, FROM 9
AND AFTER JULY 1, 2026, EACH SUBSTANCE USE DISORDER FACILITY 10
SUBJECT TO THE REQUIREMENTS OF THIS ACT THAT IS CERTIFIED BY THE 11
DEPARTMENT TO SUBMIT TO THE DEPARTMENT ON ITS INITIAL 12
CERTIFICATION APPLICATION OR ITS CERTIFICATION RENEWAL APPLICATION 13
AN ATTESTATION AS TO WHETHER IT IS COMPLYING WITH THE REQUIREMENTS 14
OF THIS ACT; TO DIRECT THE DEPARTMENT TO MONITOR COMPLIANCE BY 15
SUBSTANCE USE DISORDER FACILITIES WITH THE REQUIREMENTS OF THIS 16
ACT TO ENSURE CONTINUED ACCESS TO OPIOID USE DISORDER TREATMENT 17
FOR PREGNANT WOMEN, AND TO MAKE CERTAIN REPORTS ANNUALLY TO THE 18
PUBLIC HEALTH COMMITTEES OF THE HOUSE AND SENATE; AND FOR RELATED 19
PURPOSES. 20
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 21
SECTION 1. (1) (a) For the purposes of this section: 22
(i) "Department" means the State Department of 23
Mental Health. 24
(ii) "Onsite access" means delivery of the 25
treatment to the patient at the location of the substance use 26
disorder facility. "Onsite access" does not mean that the 27

H. B. No. 718 *HR31/R285* ~ OFFICIAL ~
25/HR31/R285
PAGE 2 (RF\JAB)

substance use disorder facility is required to maintain stock of 28
the medication-assisted treatment at the facility. 29
(iii) "Substance use disorder facility" means a 30
facility or program operated or certified by the department that 31
provides treatment to persons with substance use disorders. 32
(b) Each substance use disorder facility that provides 33
treatment for opioid use disorder to pregnant women shall provide 34
onsite access to at least one (1) form of FDA-approved opioid 35
agonist treatment. 36
(c) A substance use disorder facility is not in 37
violation of this section if prior authorization from a patient's 38
health insurer, including the Medicaid program, is required and 39
the preapproval request is denied by the patient's health insurer. 40
(2) From and after January 1, 2026, each substance use 41
disorder facility subject to the requirements of subsection (1) of 42
this section that is certified by the department shall submit to 43
the department on its initial certification application or its 44
certification renewal application an attestation as to whether it 45
is complying with the requirements of subsection (1) of this 46
section. If the facility is not fully complying with the 47
requirements of subsection (1) of this section, then the 48
attestation that the facility submits shall include a report 49
addressing its progress toward satisfying those requirements. 50
(3) The department shall monitor compliance by substance use 51
disorder facilities with the requirements of this section to 52

H. B. No. 718 *HR31/R285* ~ OFFICIAL ~
25/HR31/R285
PAGE 3 (RF\JAB)
ST: Opioid use disorder; require substance use
disorder facilities to provide pregnant women
with onsite access to certain treatments.
ensure continued access to opioid use disorder treatment for 53
pregnant women. The department also shall report annually to the 54
House Public Health and Human Services Committee and the Senate 55
Public Health and Welfare Committee the number of pregnant women 56
receiving medications for opioid use disorder and the number of 57
substance use disorder facilities providing that treatment before 58
July 1, 2025, and each year thereafter. 59
SECTION 2. This act shall take effect and be in force from 60
and after July 1, 2025. 61